Orshe

Pfizer Inc. is recalling about a million packages of two types of birth-control pills because they might not contain enough pills with active ingredients, Jennifer Corbett-Dooren reports on the News Hub. Photo: AP.

More here:  Pfizer Recalls Birth-Control Pills/a>

A new obesity study linked calorie count, versus proteins or carbs, to weight gain, Ron Winslow reports on the News Hub. Photo: AP.

View original post here:  Calories, Not Carbs, Can Lead to Weight Gain/a>

The rise of in vitro fertilization is triggering new case law as divorcing couples fight over the rights to embryos, Ashby Jones reports on the News Hub. Photo: Reuters.

See more here: When Couples Divorce, Who Keeps the Embryos?/a>

WSJ’s Anna Mathews joins the News Hub to discuss the changing face of health care in the U.S. as a result of pressure to cut costs. AP Photo.

Read the original post:  Future of U.S. Health Care is Blurred/a>

WSJ’s Emily Maltby and Jess Bravin join the News Hub to discuss the legal challenges to President Obama’s health care initiative and the hurdles facing Mary Brown, who has argued strongly against the policy. WSJ photo.

Read more here: One Woman’s Fight Against Obama’s Health Plan/a>

The Fourth Circuit Court of Appeals upholds the Obama administration’s health law, the second of three appellate courts to do so. Jess Bravin has details on the News Hub. (Photo: AP.)

More: Appeals Court Rejects Health-Law Challenges/a>

There are tons of reasons why people don’t take the medications they’ve been prescribed, including side effects, cost and complicated drug regimens.

A couple of different approaches to improving adherence are in the news today. The first is Script Your Future, a multi-year public-education campaign spearheaded by the National Consumers League and supported by health-industry companies, government agencies, nonprofits and others.

Less than two years ago, in a move analysts called “surprising” and “abrupt,” Boston Scientific said Ray Elliott would take over as CEO.

Today Elliott again surprised investors — by announcing his plans to retire at the end of the year. Boston Scientific shares fell on the news, and were down more than 9% to $6.99 in late trading.

The head of Eli Lilly’s research into Alzheimer’s disease, schizophrenia and other neurological diseases is unexpectedly leaving the company.

David Bredt’s last day at the drug maker is Feb. 25, a company spokeswoman says. He had joined Lilly in 2004.

Fellow industry drug researchers expressed surprise at the news, especially since Bredt had given no indication of his plans at recent events.

Skin types at the fair end of the spectrum are more susceptible to the burning rays of the sun — and to a higher risk for cancers and premature aging of the skin. But a little sun exposure also releases endorphins and gives us needed vitamin D. WSJ’s Melinda Beck and Laura Landro debate how good or bad the sun is for you on the News Hub.

Read the original post:  News Hub: The Sun and Your Health/a>